Semaglutide Injection 2.4 mg / 0.75 mL

Semaglutide Injection 2.4 mg / 0.75 mL is a semaglutide-based injectable formulation supplied in a pre-filled pen for subcutaneous administration.

Semaglutide is a GLP-1 receptor agonist used in eligible patients as part of an appropriate treatment plan. The 2.4 mg strength is used in approved semaglutide weight-management treatment where prescribed by a qualified healthcare professional.

Farlex Semaglutide Injection 2.4 mg / 0.75 mL is designed in a convenient pre-filled pen presentation for professional pharmaceutical use and administration as directed.

Composition: Semaglutide Injection 2.4 mg / 0.75 mL
Packing: 1 Pre-filled Pen
Route of Administration: Subcutaneous